Leonard Charles Harrison,Maryam Rashidi,Yuxia Zhang
申请号：
US14440703
公开号：
US09778269B2
申请日:
2013.03.25
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present disclosure relates to the use of a soluble CD52 glycoprotein in treating diseases regulated by effector T-cells, for example sepsis or multiple sclerosis. The present disclosure also relates to diagnostic methods based on the detection of CD52 expression levels in a subject.
